期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 166, 期 3, 页码 421-424出版社
WILEY-BLACKWELL
DOI: 10.1111/bjh.12882
关键词
Early T-precursor; child; acute lymphoblastic leukaemia
类别
资金
- Leukaemia and Lymphoma Research (UK)
- Medical Research Council (UK)
- MRC [G0300130] Funding Source: UKRI
- Medical Research Council [G0300130] Funding Source: researchfish
We investigated the outcome for children and young people with Early T-precursor acute lymphoblastic leukaemia (ETP-ALL), a recently described poor prognosis subgroup of T-ALL, treated on a contemporary protocol, UKALL 2003. After a median follow-up of 4 years and 10 months, the ETP sub-group, representing 16% of T-ALL patients, had non-significantly inferior 5-year event-free survival (76.7% vs. 84.6%, P = 0.2) and overall survival (82.4% vs. 90.9%, P = 0.1), and a higher relapse rate (18.6% vs. 9.6%, P = 0.1) compared to typical T-ALL. ETP-ALL has an intermediate risk outcome, which does not warrant experimental treatment or first remission allogeneic transplant for the group universally.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据